µ¥¸ðµ¦½º ¾È°Ë¿° ȯÀÚ¿¡¼­ Æú¸®Çí»ç¸ÞÆ¿·» ºñ±¸¾Æ´Ïµå¸¦ ÀÌ¿ëÇÑ ¾È°Ë ¼¼Ã´ÀÇ Ä¡·áÈ¿°ú
Clinical Efficacy of Polyhexamethylene Biguanide Lid Scrub on Demodex Blepharitis

´ëÇѾȰúÇÐȸÁö 2014³â 55±Ç 4È£ p.493 ~ p.497

¹®ÁØÇü(Moon Jun-hyung) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç
±èÀçÂù(Kim Jae-Chan) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç

Abstract

¸ñÀû: µ¥¸ðµ¦½º ¾È°Ë¿° ȯÀÚ¿¡¼­ Polyhexamethylene Biguanide (PHMB)¸¦ ÀÌ¿ëÇÑ ¾È°Ë ¼¼Ã´ÀÇ Ä¡·áÈ¿°ú¿¡ ´ëÇؼ­ ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.

´ë»ó°ú ¹æ¹ý: µ¥¸ðµ¦½º ¾È°Ë¿°À¸·Î Áø´ÜµÈ ȯÀÚ 31¸íÀ» ´ë»óÀ¸·Î 0.4% PHMB¸¦ ÀÌ¿ëÇÏ¿© ÇÏ·ç 2ȸ¾¿ ÃÑ 8ÁÖ°£ ¾È°Ë ¼¼Ã´À» ½ÃÇàÇÏ¿´°í, 2ÁÖ °£°ÝÀ¸·Î Ä¡·áÈ¿°ú¸¦ Æò°¡ÇÏ¿´´Ù. ³»¿ø ½Ã¸¶´Ù, ȯÀÚÀÇ ¼Ó´«½çÀ» äÃëÇÑ ÈÄ, ±¤ÇÐ Çö¹Ì°æÀ¸·Î °üÂûµÈ µ¥¸ðµ¦½º ¼ö¸¦ ±â·ÏÇÏ¿´°í, ¼¼±Øµî Çö¹Ì°æ °Ë»ç¸¦ ÅëÇØ ´«¹°¸· Æı«½Ã°£À» ÃøÁ¤ÇÏ¿´´Ù. ÁÖ°üÀû Áõ»ó¿¡ ´ëÇÑ ÁöÇ¥·Î´Â ¾È±¸Ç¥¸éÁúȯÁö¼ö(OSDI)¸¦ ÀÌ¿ëÇÏ¿´´Ù. ¶ÇÇÑ È¯ÀÚÀÇ ¼øÀÀµµ¸¦ 3´Ü°è·Î ³ª´©¾î ±â·ÏÇÏ¿©, ¼øÀÀµµ Â÷ÀÌ¿¡ µû¸¥ ¿À·ù¸¦ º¸Á¤ÇÏ¿´´Ù.

°á°ú: ¼øÀÀµµ°¡ ÁÁÁö ¾Ê¾Ò´ø 1¸íÀ» Á¦¿ÜÇÏ¿´´Ù. 8ÁÖ°£ ¾È°Ë ¼¼Ã´À» ½ÃÇàÇÑ ÈÄ, µ¥¸ðµ¦½º ¾È°Ë¿° ȯÀÚ 30¸í Áß 28¸í¿¡¼­ µ¥¸ðµ¦½º ¼ö°¡ °¨¼ÒÇÏ¿´À¸¸ç, ½ÃÇà Àü Æò±Õ 7.9 ¡¾ 3.6¸¶¸®¿¡¼­ ½ÃÇà ÈÄ 2.2 ¡¾ 2.4¸¶¸®·Î °¨¼ÒÇÏ¿´´Ù(p£¼0.01). ´«¹°¸· Æı«½Ã°£Àº ½ÃÇà Àü Æò±Õ 2.7 ¡¾ 0.8ÃÊ¿¡¼­ ½ÃÇà ÈÄ 3.4 ¡¾ 0.9ÃÊ·Î Áõ°¡ÇÏ¿´´Ù(p£¼0.01). ¶ÇÇÑ 30¸í Áß 28¸í¿¡¼­ ¾È°Ë ¼¼Ã´À» ½ÃÇàÇÑ ÈÄ ¾È±¸Ç¥¸éÁúȯÁö¼ö°¡ ½ÃÇà Àü Æò±Õ 22.0 ¡¾ 10.7Á¡¿¡¼­ ½ÃÇà ÈÄ 7.4 ¡¾ 6.0Á¡À¸·Î °¨¼ÒÇÏ¿´´Ù(p£¼0.01).

°á·Ð: µ¥¸ðµ¦½º ¾È°Ë¿°ÀÇ Ä¡·á¿¡ ÀÖ¾î PHMB¸¦ ÀÌ¿ëÇÑ ¾È°Ë ¼¼Ã´ÀÌ µ¥¸ðµ¦½º ¼ö¸¦ °¨¼Ò½ÃÅ°°í, ´«¹°¸· Æı«½Ã°£À» Áõ°¡½ÃÅ°¸ç, ¾È±¸Ç¥¸é ÁúȯÁö¼ö¸¦ °¨¼Ò½ÃÅ°´Â µ¥ È¿°ú°¡ ÀÖ´Ù.
Purpose: To evaluate the treatment efficacy of polyhexamethylene biguanide (PHMB) lid scrub on Demodex blepharitis.

Methods: Thirty-one patients diagnosed with Demodex blepharitis were evaluated every 2 weeks during 8 weeks of lid scrub treatment with 0.4% PHMB. Patients underwent epilation of 4 eyelashes in each eye, and the number of Demodex lesions was counted. The patients answered questionnaires regarding ocular surface discomfort and underwent ophthalmologic exams including slit lamp and tear breakup time (TBUT). Compliance was recorded as 1 of 3 stages (good, moderate, poor).

Results: One patient was excluded for poor compliance. After PHMB lid scrub for 8 weeks, Demodex count was reduced in 28 of 30 patients (pre-PHMB 7.9 ¡¾ 3.6 counts, post-PHMB 2.2 ¡¾ 2.4 counts, p < 0.01). In addition, TBUT showed a statistically significant increase after PHMB lid scrub (pre-PHMB 2.7 ¡¾ 0.8 seconds, post-PHMB 3.4 ¡¾ 0.9 seconds, p < 0.01). Ocular surface disease index (OSDI) score was reduced in 28 of 30 patients (pre-PHMB 22.0 ¡¾ 10.7 points, post-PHMB 7.4 ¡¾ 6.0 points, p < 0.01).

Conclusions: Eight weeks of treatment with polyhexamethylene biguanide lid scrub on Demodex blepharitis had good treatment efficacy for reducing Demodex counts and OSDI scores and increasing TBUT.

Å°¿öµå

Demodex blepharitis, Polyhexamethylene biguanide
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå